Compare ZVRA & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZVRA | NXJ |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.9M | 503.5M |
| IPO Year | 2015 | N/A |
| Metric | ZVRA | NXJ |
|---|---|---|
| Price | $8.65 | $12.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $21.71 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 74.9K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.27% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $84,388,000.00 | N/A |
| Revenue This Year | $336.43 | N/A |
| Revenue Next Year | $54.26 | N/A |
| P/E Ratio | $16.12 | ★ N/A |
| Revenue Growth | ★ 244.60 | N/A |
| 52 Week Low | $6.19 | $10.06 |
| 52 Week High | $13.16 | $12.24 |
| Indicator | ZVRA | NXJ |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 47.73 |
| Support Level | $8.12 | $12.58 |
| Resistance Level | $8.75 | $12.82 |
| Average True Range (ATR) | 0.51 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 33.21 | 26.92 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.